Korean physicians expressed their high expectations for SpaceOAR, Boston Scientific's new medical device that reduces side effects in radiation therapy for prostate cancer patients.SpaceOAR device reduces the amount of radiation delivered to the rectum by injecting a hydrogel barrier between the pro
PARIS -- “Lung cancer treatment is developing day by day, but the domestic health insurance benefits and other treatment environments fall far short of supporting the development.”Professor Ahn Myung-joo of the Department of Hemato-oncology at Samsung Medical Center (SMC) said so on Sunday when aske
Lilly Korea said it released Retevmo (selpercatinib), the first RET (rearranged during transfection) targeted therapy, in Korea on Wednesday.The market release follows Retevmo’s winning the regulatory nod in March to treat adult patients with metastatic RET fusion-positive non-small cell lung cancer
Citizens can receive the Covid-19 and influenza vaccination simultaneously on each arm, a top quarantine advisor said."This is because the side effects are similar to receiving the two vaccines individually, and most of the people have already received a Covid-19 vaccine at least once," said Jung Ki
The Ministry of Food and Drug Safety has added tumor lysis syndrome (TLS) to the adverse effects of sorafenib-based treatments for liver cancer.On Tuesday, the Drug Safety Assessment Division of the ministry made public changes in permitted contents – directions for use of medicine – of sorafenib dr
Qurient said it entered into a joint development agreement with MSD (Merck in the U.S.) for clinical research on the combination therapy of Q901, a selective CDK7 inhibitor, and MSD’s Keytruda, an anti-programmed cell death protein1 (PD-1) immunotherapy.Under the accord, the two companies will condu
As the government moves toward allowing the publication of non-paid medical expense information by one-line platforms, such as “Gangnam Sister," plastic surgeons opposed the move, saying it would allow patient solicitation and lower medical quality.On Sept. 5, the government held an online meeting o
Over the past 10 years, the overall death rate in Seoul continued to decline but pneumonia deaths, one of the key health indicators, rather increased, a government report showed.The Seoul Health Foundation (SHF), run under the Seoul Metropolitan Government, released a report analyzing changes in the
A joint research team, consisting of researchers from Yonsei University College of Medicine and Severance Hospital, has developed a therapeutic agent that increases the efficacy of glioblastoma (GBM) anticancer drugs by 136 percent.GBM is a cancer that occurs in nerve cells in the brain. The cancer
Amid the prolonged Covid-19 pandemic, the discussion on how to distribute limited medical resources has emerged as a global topic. In the U.K. in particular, interest is growing in people with developmental disabilities placed in the blind spots of healthcare and welfare, although they account for o
MedPacto said Tuesday that it has presented a poster study on the interim clinical data of the Vactosertib combination therapy related to pancreatic cancer during the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer.The study is an investigator-initiated clinic
HLB, a Korean biotech firm, said Tuesday it would submit a new drug application (NDA) to the FDA for marketing approval of an anticancer drug, rivoceranib, in early 2023.HLB said the FDA’s designation of camrelizumab, used in combination with rivoceranib, as an orphan drug would speed up the regulat
Due to the continuing Covid-19 epidemic, health officials said that it is too early to lift the indoor mask mandate or quarantine obligations for confirmed patients.However, authorities stressed that they may review lifting rules when Korea enters a "stable period.""Regarding lifting of indoor masks
More than a month has passed since the Yoon Suk-yeol administration launched the “Covid-19 Special Response Team” under the slogan of “scientific quarantine.”However, the team has neither appointed members nor held a single meeting.Rep. Kim Won-i of the opposition Democratic Party of Korea (DPK) rem
A research team at St. Mary's Hospital has discovered a biomarker that can predict the severity and recovery of dysphagia, or swalling difficulties, after a stroke.Dysphagia is a major cause of bacterial aspiration pneumonia as well as malnutrition and dehydration, affecting the overall recovery of
The U.S. Food and Drug Administration recommended Golden Biotechnology Corp., a Taiwanese biopharmaceutical company, to conduct an additional clinical trial of antroquinonol, a Covid-19 treatment candidate, BNC Korea said.In August 2020, Golden Biotech and BNC Korea signed an agreement for the latte
U.S. President Joe Biden on Monday signed an executive order implementing a new initiative aiming to boost biomanufacturing in pharmaceuticals.The initiative aims to help expand U.S. biomanufacturing capabilities and reduce reliance on China.According to people familiar with the matter, the order la
In recent years, the South Korean media have been churning out reports of teens overdosing on Fentanyl, a powerful narcotic analgesic similar to morphine but 50 to 100 times more potent.To prevent the abuse or misuse of the drug, Rep. Kang Sun-woo of the Democratic Party and 10 other lawmakers on Th
The Ministry of Food and Drug Safety imposed a three-month manufacturing suspension on two nutritional injection products of Samsung Pharm, GC Wellbeing Amino Inj. And GC WellBbing Neuramin Inc., last Thursday.The reason for the disposition is the “violation of the regulations on management responsi
PARIS – A Korean expert has given a positive evaluation to the phase 3 clinical trial results of VEGFR2 Tigit Tyrosine Kinase Inhibitor (TKI), “rivoceranib,” which proved effective in the first-line treatment of liver cancer combined with the anti-PD-1 immuno-cancer drug, "camrelizumab."Rivoceranib